BNP Paribas Exane Sees Big Upside for Astera Labs
BNP Paribas Exane initiates coverage on Astera Labs with an Outperform rating and $225 target, citing strong long-term opportunities despite recent stock weakness.
/ 2 items
BNP Paribas Exane initiates coverage on Astera Labs with an Outperform rating and $225 target, citing strong long-term opportunities despite recent stock weakness.
Astera Labs partners with Arm Total Design to deliver chiplet connectivity for AI infrastructure using PCIe, CXL, and UALink amid recent stock volatility.